Phase 1, Single-Dose and Multiple-Dose Continuous Intravenous Infusions of TNP-2092 for Injection in Healthy Chinese Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is a phase 1, single-center, randomized, double-blind, placebo-controlled, dose-escalation clinical trial of single and multiple intravenous doses of TNP-2092 for injection in healthy Chinese participants.
Epistemonikos ID: df72b2c926885ba7df693726bc1c81a7907df451
First added on: May 16, 2024